Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Stefania Orini"'
Autor:
Benedetta Gottardelli, Roberto Gatta, Leonardo Nucciarelli, Andrada Mihaela Tudor, Erica Tavazzi, Mauro Vallati, Stefania Orini, Nicoletta Di Giorgi, Andrea Damiani
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Artificial intelligence (AI) has become a pivotal tool in advancing contemporary personalised medicine, with the goal of tailoring treatments to individual patient conditions. This has heightened the demand for access to diverse d
Externí odkaz:
https://doaj.org/article/035e319bf17347ed9f0449ed221bd2de
Autor:
Mauro Vallati, Stefania Orini, Mariagrazia Lorusso, Mariachiara Savino, Roberto Gatta, Massimiliano Filosto
Publikováno v:
The International FLAIRS Conference Proceedings. 36
In the last decade, Process Mining has become a significant field to help healthcare process experts understand and gain relevant insights about the processes they execute. One of the most challenging questions in Process Mining, and particularly in
Publikováno v:
Aging Clinical and Experimental Research. 34:3151-3153
Publikováno v:
Aging clinical and experimental research. 34(12)
Since the late ninety, research on Alzheimer's disease has been focused on the search of drugs able to modify the disease course. Patients and caregivers waiting for news on this topic, received enthusiastically the advice of the approval of Aducanum
Publikováno v:
Artificial Intelligence in Healthcare ISBN: 9789811952715
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cd6606a675196f41a3440fe824e2a33
https://doi.org/10.1007/978-981-19-5272-2_2
https://doi.org/10.1007/978-981-19-5272-2_2
Autor:
Tomas Lapinskas, Luis Marco-Ruiz, Lucia Sacchi, Olivier Michielin, Stefania Orini, Antanas Montvila, Alessandro Stefanini, Antonio Martinez-Millana, Erica Tavazzi, Roberto Gatta, Mauro Vallati, Berardino De Bari, Jacopo Lenkowicz, Jorge Munoz-Gama, Michel A. Cuendet, Carlos Fernandez-Llatas, Zoe Valero-Ramon, Mar Marcos, Niels Martin, Maurizio Castellano
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 6616, p 6616 (2020)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
International journal of environmental research and public health, Basel : MDPI, 2020, vol. 17, no. 18, p. 1-19
Repositori Universitat Jaume I
Universitat Jaume I
International Journal of Environmental Research and Public Health
International journal of environmental research and public health, vol. 17, no. 18, pp. E6616
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
International journal of environmental research and public health, Basel : MDPI, 2020, vol. 17, no. 18, p. 1-19
Repositori Universitat Jaume I
Universitat Jaume I
International Journal of Environmental Research and Public Health
International journal of environmental research and public health, vol. 17, no. 18, pp. E6616
In the age of Evidence-Based Medicine, Clinical Guidelines (CGs) are recognized to be an indispensable tool to support physicians in their daily clinical practice. Medical Informatics is expected to play a relevant role in facilitating diffusion and
Autor:
Melissa Romano, Stefania Orini, Monica Bertocchi, Silvana Archetti, Eugenia Chitò, Michela Pievani, Giovanni B. Frisoni, Milena Cobelli, Sandra Rosini, Silvia Magnaldi, Samantha Galluzzi, Orazio Zanetti, Cristina Geroldi, Lorenzo Pini, Mauro Morassi, Cristian Bonvicini, Roberta Baruzzi, Maria Cotelli
Publikováno v:
Brain Imaging and Behavior (2020)
Age at symptom onset (AAO) underlies different Alzheimer's disease (AD) clinical variants: late-onset AD (LOAD) is characterized by memory deficits, while early-onset AD (EOAD) presents predominantly with non-memory symptoms. The involvement of diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f649b3df0f52b5690dbf136a6cb3ab0a
https://archive-ouverte.unige.ch/unige:140841
https://archive-ouverte.unige.ch/unige:140841
Autor:
Javier Arbizu, Valentina Garibotto, Peter J. Nestor, Zuzana Walker, Federica Agosta, Cristina Festari, Femke H. Bouwman, Federica Gandolfo, Flavio Nobili, Alexander Drzezga, Stefania Orini, Marina Boccardi, Daniele Altomare
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European journal of nuclear medicine and molecular imaging 45(9), 1534-1545 (2018). doi:10.1007/s00259-018-4031-2
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1534-1545
EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders 2018, ' Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1534-1545 . https://doi.org/10.1007/s00259-018-4031-2
European journal of nuclear medicine and molecular imaging 45(9), 1534-1545 (2018). doi:10.1007/s00259-018-4031-2
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1534-1545
EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders 2018, ' Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1534-1545 . https://doi.org/10.1007/s00259-018-4031-2
Purpose: There are no comprehensive guidelines for the use of FDG PET in the following three clinical scenarios: (1) diagnostic work-up of patients with idiopathic Parkinson’s disease (PD) at risk of future cognitive decline, (2) discriminating idi
Autor:
Zuzana Walker, Peter J. Nestor, Cristina Festari, Giovanni B. Frisoni, Daniele Altomare, Jasmine Rivolta, Federica Agosta, Alexander Drzezga, Stefania Orini, Flavio Nobili, Marina Boccardi, Henryk Barthel, Javier Arbizu, Femke H. Bouwman
Publikováno v:
EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders 2018, ' Clinical utility of FDG-PET for the clinical diagnosis in MCI ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1497-1508 . https://doi.org/10.1007/s00259-018-4039-7
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1497-1508
European journal of nuclear medicine and molecular imaging 45(9), 1497-1508 (2018). doi:10.1007/s00259-018-4039-7
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1497-1508
European journal of nuclear medicine and molecular imaging 45(9), 1497-1508 (2018). doi:10.1007/s00259-018-4039-7
Purpose: We aim to report the quality of accuracy studies investigating the utility of [18F]fluorodeoxyglucose (FDG)-PET in supporting the diagnosis of prodromal Alzheimer’s Disease (AD), frontotemporal lobar degeneration (FTLD) and prodromal demen
Autor:
Federica Agosta, Stefania Orini, Flavio Nobili, Marina Boccardi, Cristina Festari, Alexander Drzezga, Javier Arbizu, Karl Herholz, Giovanni B. Frisoni, Peter J. Nestor, Zuzana Walker, Femke H. Bouwman, Daniele Altomare
Publikováno v:
European journal of nuclear medicine and molecular imaging 45(9), 1487-1496 (2018). doi:10.1007/s00259-018-4032-1
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1487-1496
EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders 2018, ' Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1487-1496 . https://doi.org/10.1007/s00259-018-4032-1
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, No 9 (2018) pp. 1487-1496
EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders 2018, ' Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, pp. 1487-1496 . https://doi.org/10.1007/s00259-018-4032-1
Purpose: To assess the clinical utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of early signs of neurodegeneration in conditions of increased risk for Alzheimer’s disease (AD) as defined by: subjective cognit